Akpınar YY, Baykan Z, Naçar M, Gün İ, Çetinkaya F (2011) Knowledge, attitude about breast cancer and practice of breast cancer screening among female health care professionals: a study from Turkey. Asian Pac J Cancer Prev 12(11):3063–3068
American College of Obstetricians and Gynecologists (2017) Committee opinion 691: carrier screening for genetic conditions. Obstet Gynecol 129(3):e41–e55
Angelis A, Tordrup D, Kanavos P (2015) Socio-economic burden of rare diseases: a systematic review of cost of illness evidence. Health Policy 119(7):964–979
Arnold WD, Kassar D, Kissel JT (2015) Spinal muscular atrophy: diagnosis and management in a new therapeutic era. Muscle Nerve 51(2):157–167
Aydemir H, Ayata MK (2022) Sağlık Bilimleri Fakültesi Öğrencilerinin Genetik Hastalıklar, prenatal Testler ve Genetik Konusundaki Bilgi Düzeyleri. Kırşehir Ahi Evran Üniversitesi Sağlık Bilimleri Dergisi 6(3):174–183
Bagga P, Singh S, Ram G, Kapil S, Singh A (2024) Diving into progress: a review on current therapeutic advancements in spinal muscular atrophy. Front Neurol. 15:1368658.
Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, Arconada-López B, Ruiz-García B, De la Paz PM, Alonso-Ferreira V (2023) Psychosocial impact at the time of a rare disease diagnosis. PLoS ONE, 18(7), e0288875
Berenson AB, Rahman M, Hirth JM, Rupp RE, Sarpong KO (2015) A brief educational intervention increases providers’ human papillomavirus vaccine knowledge. Hum Vaccines Immunotherapeutics 11(6):1331–1336
Bodamer OA. Spinal muscular atrophy - UpToDate. UpToDate. Published 2022. Accessed June 10, 2024. https://www.uptodate.com/contents/spinal-muscular-atrophy?search=sma&source=search_result&selectedTitle=1~46&usage_type=default&display_rank=1#H7.
Choma K, McKeever AE (2015) Cervical Cancer screening in adolescents: an evidence-based Internet Education Program for Practice Improvement among Advanced Practice nurses. Worldviews Evidence‐Based Nurs 12(1):51–60
D’Amico A, Mercuri E, Tiziano FD, Bertini E (2011) Spinal muscular atrophy. Orphanet J Rare Dis 6:1–10
Fidan Ç, Akdur R, Ünver ÇN, Şahin ÖC, Alper AB (2022) The two essential components of a comprehensive rare disease control program. In 6th International and 24th National Congress on Public Health
Fishbein M, Ajzen I (2009) Predicting and changing behavior: the reasoned Action Approach, 1st edn. Psychology
Forman J, Taruscio D, Llera VA, Barrera LA, Coté TR, Edfjäll C, … International Conference for Rare, Diseases, Drugs O, ICORD) (2012) (. The need for worldwide policy and action plans for rare diseases. Acta Paediatrica, 101(8), 805–807
Kalyoncu C, Işıklı B, Özalp S, Küçük N (2003) Osmangazi Üniversitesi Kadın Hastalıkları ve Doğum Polikliniğine başvuruların pap smear hakkında bilgi tutum ve davranışları. Sağlık Ve Toplum 13(2):60–66
Kariyawasam DS, D’Silva AM, Vetsch J, Wakefield CE, Wiley V, Farrar MA (2021) We needed this: perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy. EClinicalMedicine, 33
Kaya C, Üstü Y, Özyörük E, Aydemir Ö, Şimşek Ç, Şahin AD (2017) Sağlık Çalışanlarının Kanser Taramaları Hakkındaki Bilgi, Tutum ve Davranışlarının Değerlendirilmesi. Ankara Med J, 17(1)
Koç İ (2022) Türkiye’de Akraba evliliklerinin yaygınlığının değişimi ve dirençli grupların belirlenmesi: 2018 Türkiye Nüfus ve Sağlık Araştırması’ndan evlilik kuşaklarına göre analizler. Turkish J Public Health 20(3):423–438
Laccourreye O, Maisonneuve H (2019) French scientific medical journals confronted by developments in medical writing and the transformation of the medical press. Eur Annals Otorhinolaryngol Head Neck Dis 136(6):475–480
Lin CW, Kalb SJ, Yeh WS (2015) Delay in diagnosis of spinal muscular atrophy: a systematic literature review. Pediatr Neurol 53(4):293–300
Moultrie RR, Kish-Doto J, Peay H, Lewis MA (2016) A review on spinal muscular atrophy: awareness, knowledge, and attitudes. J Genet Couns 25(5):892–900
Muralidharan K, Wilson RB, Ogino S, Nagan N, Curtis C, Schrijver I (2011) Population carrier screening for spinal muscular atrophy: a position statement of the Association for Molecular Pathology. J Mol Diagn 13(1):3–6
Article PubMed PubMed Central Google Scholar
Musa J, Achenbach CJ, O’Dwyer LC, Evans CT, McHugh M, Hou L, Jordan N (2017) Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis. PLoS ONE, 12(9), e0183924
Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB (2002) Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet 110(4):301–307
Öz M, Özel Ş, Ustun Y (2019) Üçüncü basamak sağlık kuruluşu çalışanlarının serviks kanseri taraması konusundaki bilgi ve tutumlarının değerlendirilmesi. Jinekoloji-Obstetrik Ve Neonatoloji Tıp Dergisi 16(4):220–224
Özdemir Y, Arısoy R, Semiz A, Şanlıkan F, Akar G, Çağ M (2022) Carrier frequency of spinal muscular atrophy in Turkish population. Perinat J 30(1):57–60
Öztürk M (2020) ÇOMÜ Tıbbi Genetik tanı merkezi’nde spinal musküler atrofi ön tanısı veya taşıyıcılığı açısından genotiplendirilen olguların SMN1/SMN2 genlerinin kopya sayılarının retrospektif analizi. [Unpublished thesis]. Çanakkale Onsekiz Mart Üniversitesi
Prior TW (2008) Carrier screening for spinal muscular atrophy. Genet Sci 10(11):840–842
Prior TW, Leach ME, Finanger E (2000) Spinal Muscular Atrophy. [Updated 2020 Dec 3]. In: Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2024
T.C. Ministry of Health, General Directorate of Public Health, Department of Child and Adolescent Health (2023) Evlilik Öncesi Spinal Musküler Atrofi (SMA) Taşıyıcı Tarama Programı. https://hsgm.saglik.gov.tr/tr/tarama-programlari/evlilik-oncesi-sma-tasiyici-tarama-programi.html
留言 (0)